{"hands_on_practices": [{"introduction": "The initial management of acute upper gastrointestinal bleeding hinges on rapid risk stratification to determine the appropriate level of care. The Glasgow-Blatchford Score (GBS) is a validated, pre-endoscopy tool designed for this purpose. This exercise provides direct practice in calculating the GBS from clinical and laboratory data, a fundamental skill for triaging patients and making critical decisions about inpatient admission versus potential outpatient management [@problem_id:4789206].", "problem": "A $54$-year-old male presents to the emergency department with acute melena and lightheadedness. Vital signs show systolic blood pressure (SBP) $=92\\,\\mathrm{mmHg}$ and pulse $=112$ per minute. Laboratory testing demonstrates Blood Urea Nitrogen (BUN) $=45\\,\\mathrm{mg/dL}$ and hemoglobin $=9.2\\,\\mathrm{g/dL}$. He denies syncope. His past medical history is notable for chronic hepatic disease; he has no history of heart failure. Using the widely accepted components of the Glasgow-Blatchford Score (GBS) for acute upper gastrointestinal bleeding and the standard conversion between Blood Urea Nitrogen and blood urea, compute the total GBS for this patient and determine whether outpatient management is appropriate under the conventional low-risk threshold. Express your final answer as the single integer value of the computed GBS; no units are required. No rounding is necessary.", "solution": "The problem statement is subjected to validation.\n\n### Step 1: Extract Givens\n- Age: $54$-year-old male\n- Presentation: acute melena, lightheadedness\n- Vital Signs: Systolic Blood Pressure (SBP) $= 92\\,\\mathrm{mmHg}$, Pulse $= 112$ per minute\n- Laboratory Values: Blood Urea Nitrogen (BUN) $= 45\\,\\mathrm{mg/dL}$, Hemoglobin (Hb) $= 9.2\\,\\mathrm{g/dL}$\n- Symptoms: Denies syncope\n- Past Medical History: Chronic hepatic disease, no history of heart failure\n- Task: Compute the Glasgow-Blatchford Score (GBS) and determine the appropriateness of outpatient management based on the conventional low-risk threshold.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, well-posed, and objective. It describes a clinically realistic scenario of acute upper gastrointestinal bleeding and requires the application of a standard, validated medical risk-stratification tool, the Glasgow-Blatchford Score (GBS). All data required for the GBS calculation are provided, and there are no internal contradictions or ambiguities. The problem is formalizable as a direct application of the scoring system's rules.\n\n- **Scientific or Factual Unsoundness**: None. The GBS is a widely used and validated score. The clinical presentation is classic for upper GI bleeding.\n- **Non-Formalizable or Irrelevant**: None. The task is a direct, formal calculation.\n- **Incomplete or Contradictory Setup**: None. All necessary variables for the GBS are provided.\n- **Unrealistic or Infeasible**: None. The patient's vital signs and lab values are plausible for this clinical condition.\n- **Ill-Posed or Poorly Structured**: None. The GBS has a defined algorithm that yields a unique integer score.\n- **Pseudo-Profound, Trivial, or Tautological**: None. The problem requires specific knowledge of the GBS components and a unit conversion, representing a non-trivial application of a clinical algorithm.\n- **Outside Scientific Verifiability**: None. The calculation is deterministic and verifiable.\n\n### Step 3: Verdict and Action\nThe problem is valid and can be solved as stated.\n\n### Solution\nThe objective is to compute the Glasgow-Blatchford Score (GBS) for the given patient. The GBS is an integer score calculated by summing points assigned to several clinical and laboratory parameters.\n\nThe components of the GBS and their corresponding point values are as follows:\n\n1.  **Blood Urea:**\n    - $\\ge 6.5$ and $ 8.0$ mmol/L: $2$ points\n    - $\\ge 8.0$ and $ 10.0$ mmol/L: $3$ points\n    - $\\ge 10.0$ and $ 25.0$ mmol/L: $4$ points\n    - $\\ge 25.0$ mmol/L: $6$ points\n\n2.  **Hemoglobin (for men):**\n    - $\\ge 12.0$ and $ 13.0$ g/dL: $1$ point\n    - $\\ge 10.0$ and $ 12.0$ g/dL: $3$ points\n    - $ 10.0$ g/dL: $6$ points\n\n3.  **Systolic Blood Pressure (SBP):**\n    - $100-109$ mmHg: $1$ point\n    - $90-99$ mmHg: $2$ points\n    - $ 90$ mmHg: $3$ points\n\n4.  **Other Markers:**\n    - Pulse $\\ge 100$ /min: $1$ point\n    - Presence of melena: $1$ point\n    - Presence of syncope: $2$ points\n    - History of hepatic disease: $2$ points\n    - History of cardiac failure: $2$ points\n\nWe will now calculate the score for the patient based on the provided data.\n\n**1. Blood Urea Score:**\nThe patient's Blood Urea Nitrogen (BUN) is given as $45$ $\\mathrm{mg/dL}$. The GBS uses blood urea concentration in mmol/L. The standard conversion from BUN (in mg/dL) to urea (in mmol/L) is given by the formula:\n$$ \\text{Urea (mmol/L)} = \\frac{\\text{BUN (mg/dL)}}{k} $$\nwhere the conversion factor $k$ is approximately $2.8$. This factor arises from the ratio of the molecular weights of urea and the two nitrogen atoms within it, and the unit conversions.\nUsing the patient's data:\n$$ \\text{Urea} = \\frac{45}{2.8} \\approx 16.071 \\text{ mmol/L} $$\nThis value falls within the range $\\ge 10.0$ and $ 25.0$ mmol/L.\nTherefore, the score for blood urea is $4$ points.\n\n**2. Hemoglobin Score:**\nThe patient is male and has a hemoglobin level of $9.2$ $\\mathrm{g/dL}$. This value is less than $10.0$ $\\mathrm{g/dL}$.\nTherefore, the score for hemoglobin is $6$ points.\n\n**3. Systolic Blood Pressure Score:**\nThe patient's SBP is $92$ $\\mathrm{mmHg}$. This value falls within the range $90-99$ $\\mathrm{mmHg}$.\nTherefore, the score for SBP is $2$ points.\n\n**4. Other Markers Score:**\n- **Pulse:** The patient's pulse is $112$ per minute, which is $\\ge 100$. This contributes $1$ point.\n- **Melena:** The patient presents with melena. This contributes $1$ point.\n- **Syncope:** The patient denies syncope. This contributes $0$ points.\n- **Hepatic Disease:** The patient has a history of chronic hepatic disease. This contributes $2$ points.\n- **Cardiac Failure:** The patient has no history of cardiac failure. This contributes $0$ points.\nThe total score from other markers is $1 + 1 + 0 + 2 + 0 = 4$ points.\n\n**Total Glasgow-Blatchford Score:**\nThe total GBS is the sum of the points from each category:\n$$ \\text{Total GBS} = (\\text{Urea Score}) + (\\text{Hb Score}) + (\\text{SBP Score}) + (\\text{Other Markers Score}) $$\n$$ \\text{Total GBS} = 4 + 6 + 2 + 4 = 16 $$\n\nThe total GBS for this patient is $16$.\n\nThe problem also asks to determine if outpatient management is appropriate. The conventional threshold for low-risk status, qualifying a patient for potential outpatient management, is a GBS of $0$. Since this patient's score is $16$, which is significantly greater than $0$, he is classified as high-risk and is not a candidate for outpatient management. He requires inpatient admission for resuscitation and urgent evaluation, likely including endoscopy. The final answer required is only the numerical value of the score.", "answer": "$$\\boxed{16}$$", "id": "4789206"}, {"introduction": "A clinical score provides a risk category, but its true power lies in understanding how it modifies a patient's probability of having a specific outcome. Using Bayes' theorem, we can translate a test's performance characteristics—sensitivity and specificity—into a clinically actionable post-test probability. This practice demonstrates how to calculate the positive predictive value for a GBS cutoff, allowing you to move beyond a simple \"high-risk\" label to a quantitative estimate of the need for intervention [@problem_id:4789230].", "problem": "An emergency department cohort of adults presenting with suspected acute upper gastrointestinal bleeding is being triaged using the Glasgow-Blatchford Score (GBS). The Glasgow-Blatchford Score (GBS) cutoff of GBS $\\geq 7$ is considered a positive test for the clinical target of “requiring endoscopic therapy within the index hospitalization.” Let the target event be denoted by $D$ (“requires endoscopic therapy”) and the test result by $T^{+}$ (“GBS $\\geq 7$”). The following well-tested diagnostic characteristics are available from prior validation studies in similar populations: sensitivity $P(T^{+}\\,|\\,D) = 0.85$ and specificity $P(T^{-}\\,|\\,\\neg D) = 0.68$. In the current cohort, the pretest probability of $D$ is $P(D) = 0.40$.\n\nStarting from the fundamental definition of Bayes theorem and the core definitions of sensitivity and specificity, derive an expression for, and then compute, the posttest probability $P(D\\,|\\,T^{+})$ in this cohort. Express your final answer as a decimal and round to four significant figures.", "solution": "The user wants me to solve the problem.\nThe problem is valid. It is a standard application of Bayes' theorem in a medical diagnostics context. The problem is scientifically grounded, well-posed, objective, and contains all necessary information for a unique solution.\n\nThe objective is to derive an expression for and compute the posttest probability of requiring endoscopic therapy given a positive test result, denoted as $P(D\\,|\\,T^{+})$. This quantity is also known as the positive predictive value (PPV).\n\nThe derivation begins with the fundamental definition of conditional probability, which leads to Bayes' theorem. Let $D$ be the event that the patient requires endoscopic therapy, and let $T^{+}$ be the event of a positive test result (Glasgow-Blatchford Score $\\geq 7$). The probability of $D$ given $T^{+}$ is:\n$$ P(D\\,|\\,T^{+}) = \\frac{P(D \\cap T^{+})}{P(T^{+})} $$\nThe joint probability $P(D \\cap T^{+})$ can be rewritten using the definition of conditional probability for $P(T^{+}\\,|\\,D)$:\n$$ P(T^{+}\\,|\\,D) = \\frac{P(D \\cap T^{+})}{P(D)} \\implies P(D \\cap T^{+}) = P(T^{+}\\,|\\,D) P(D) $$\nSubstituting this into the first equation yields the common form of Bayes' theorem:\n$$ P(D\\,|\\,T^{+}) = \\frac{P(T^{+}\\,|\\,D) P(D)}{P(T^{+})} $$\nThe term in the numerator, $P(T^{+}\\,|\\,D)$, is the sensitivity of the test, and $P(D)$ is the pretest probability or prevalence of the condition. Both are provided.\n\nThe denominator, $P(T^{+})$, is the total probability of a positive test result. It must be expanded using the law of total probability. A positive test can occur in two mutually exclusive scenarios: a true positive (the patient has the condition $D$ and tests positive $T^{+}$) or a false positive (the patient does not have the condition $\\neg D$ and tests positive $T^{+}$).\n$$ P(T^{+}) = P(T^{+} \\cap D) + P(T^{+} \\cap \\neg D) $$\nUsing the definition of conditional probability again for each term:\n$$ P(T^{+}) = P(T^{+}\\,|\\,D)P(D) + P(T^{+}\\,|\\,\\neg D)P(\\neg D) $$\nNow, we can substitute this expanded form of $P(T^{+})$ into the denominator of Bayes' theorem. This gives the full expression for the posttest probability in terms of the initial givens:\n$$ P(D\\,|\\,T^{+}) = \\frac{P(T^{+}\\,|\\,D) P(D)}{P(T^{+}\\,|\\,D)P(D) + P(T^{+}\\,|\\,\\neg D)P(\\neg D)} $$\nThe problem provides sensitivity, $P(T^{+}\\,|\\,D)$, and specificity, $P(T^{-}\\,|\\,\\neg D)$. The term $P(T^{+}\\,|\\,\\neg D)$ is the false positive rate, which is the complement of the specificity:\n$$ P(T^{+}\\,|\\,\\neg D) = 1 - P(T^{-}\\,|\\,\\neg D) $$\nSimilarly, the probability of not having the condition, $P(\\neg D)$, is the complement of the prevalence:\n$$ P(\\neg D) = 1 - P(D) $$\nSubstituting these into our derived equation gives the final expression for $P(D\\,|\\,T^{+})$ purely in terms of sensitivity, specificity, and prevalence:\n$$ P(D\\,|\\,T^{+}) = \\frac{P(T^{+}\\,|\\,D) P(D)}{P(T^{+}\\,|\\,D)P(D) + (1 - P(T^{-}\\,|\\,\\neg D))(1 - P(D))} $$\nThis is the derived expression. We now proceed with the computation.\n\nThe given values are:\nSensitivity: $P(T^{+}\\,|\\,D) = 0.85$\nSpecificity: $P(T^{-}\\,|\\,\\neg D) = 0.68$\nPretest probability (prevalence): $P(D) = 0.40$\n\nFirst, we calculate the probabilities of the complementary events:\nProbability of not requiring endoscopic therapy:\n$$ P(\\neg D) = 1 - P(D) = 1 - 0.40 = 0.60 $$\nProbability of a false positive, $P(T^{+}\\,|\\,\\neg D)$:\n$$ P(T^{+}\\,|\\,\\neg D) = 1 - P(T^{-}\\,|\\,\\neg D) = 1 - 0.68 = 0.32 $$\nNext, we calculate the total probability of a positive test, $P(T^{+})$:\n$$ P(T^{+}) = P(T^{+}\\,|\\,D)P(D) + P(T^{+}\\,|\\,\\neg D)P(\\neg D) $$\n$$ P(T^{+}) = (0.85)(0.40) + (0.32)(0.60) $$\n$$ P(T^{+}) = 0.34 + 0.192 = 0.532 $$\nFinally, we substitute the values into the formula for $P(D\\,|\\,T^{+})$:\n$$ P(D\\,|\\,T^{+}) = \\frac{P(T^{+}\\,|\\,D) P(D)}{P(T^{+})} = \\frac{(0.85)(0.40)}{0.532} = \\frac{0.34}{0.532} $$\n$$ P(D\\,|\\,T^{+}) \\approx 0.63909774436... $$\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $6$, $3$, $9$, and $0$. The fifth significant figure is $9$, which is $\\geq 5$, so we round up the fourth significant figure.\n$$ P(D\\,|\\,T^{+}) \\approx 0.6391 $$", "answer": "$$ \\boxed{0.6391} $$", "id": "4789230"}, {"introduction": "Advanced clinical reasoning involves not just calculating risks but also weighing the potential harms and benefits of different management strategies. This problem challenges you to build a formal decision-making algorithm for a patient with lower gastrointestinal bleeding by integrating multiple data points, probabilistic reasoning, and expected value theory. This capstone exercise will help you synthesize information to make a principled choice between expectant management and immediate intervention, reflecting the highest level of evidence-based practice [@problem_id:4789178].", "problem": "A $62$-year-old man presents with mild lower gastrointestinal bleeding (LGIB) characterized by two episodes of small-volume bright red blood per rectum over $6$ hours. He reports no dizziness and is comfortable ambulating. On arrival and at $2$-hour intervals, his vital signs are: systolic blood pressure $118\\,\\mathrm{mmHg}$, heart rate $84\\,\\mathrm{beats/min}$, respiratory rate $14\\,\\mathrm{breaths/min}$, and oxygen saturation $98\\%$ on room air. Orthostatic testing shows no systolic drop and no tachycardic response. Laboratory data show hemoglobin decreasing from $13.4\\,\\mathrm{g/dL}$ to $12.8\\,\\mathrm{g/dL}$ over $6$ hours, lactate $1.2\\,\\mathrm{mmol/L}$, international normalized ratio $1.0$, platelets $220{,}000/\\mu\\mathrm{L}$. He takes no antiplatelet agents and no anticoagulants. Stool frequency is baseline, and there is no abdominal pain. There is no history of inflammatory bowel disease or diverticulosis.\n\nYou are asked to construct an algorithm to decide between expectant management versus immediate intervention for mild LGIB by integrating bleeding severity, hemodynamic stability, and likelihood of spontaneous cessation. Use the following clinically grounded facts as the fundamental starting base: mild LGIB frequently ceases spontaneously within $12$ hours with a baseline probability near $0.8$, hemodynamic stability and small hemoglobin change increase the likelihood of spontaneous cessation, observed ongoing hematochezia in the last hour decreases it, and major complications from urgent therapeutic colonoscopy or angiographic embolization occur in about $0.01$ of cases. For the purpose of decision analysis, assign a normalized harm weight $h_c = 1$ to a major procedural complication and $h_w = 0.05$ to morbidity from continued mild bleeding if it does not stop spontaneously. For Bayesian updating, use multiplicative likelihood factors: hemodynamic stability increases the odds of spontaneous cessation by a factor of $1.5$, a small hemoglobin drop less than $1\\,\\mathrm{g/dL}$ increases the odds by $1.3$, and observed ongoing hematochezia within the last hour decreases the odds by $0.6$.\n\nWhich of the following algorithms best operationalizes a principled decision between expectant management and immediate intervention and, when applied to this patient, selects the appropriate management?\n\nA. Screen first for hemodynamic instability using systolic blood pressure, heart rate, orthostasis, and lactate; if stable, estimate the probability of spontaneous cessation by Bayesian updating from a prior $0.8$ using the provided likelihood factors for stability, hemoglobin change, and witnessed ongoing bleeding; then compare the posterior probability to a decision threshold derived from expected-value balancing of waiting versus intervening, where the threshold is defined implicitly by equating expected harms using the provided complication risk and harm weights; choose expectant management if the posterior probability exceeds the threshold, with dynamic escalation to computed tomography angiography (CTA) or urgent colonoscopy if instability emerges or the posterior probability falls below the threshold.\n\nB. Use a hemoglobin-only rule: if hemoglobin is below $10\\,\\mathrm{g/dL}$, transfuse and observe; if hemoglobin is $10\\,\\mathrm{g/dL}$ or higher, perform immediate colonoscopy to shorten length of stay, regardless of hemodynamics or likelihood of spontaneous cessation.\n\nC. Use the number of bloody stools as the principal determinant: if more than $3$ bloody stools occur within $6$ hours, obtain immediate CTA; otherwise, discharge with outpatient colonoscopy, without explicit consideration of hemodynamics, probability of spontaneous cessation, or procedural risk.\n\nD. Apply a universal early-intervention pathway: for any LGIB with ongoing hematochezia on arrival, obtain immediate CTA followed by colonoscopy if CTA is negative, because procedural control reduces uncertainty; do not incorporate probability-of-cessation estimates or expected-value balancing.\n\nSelect the single best option.", "solution": "The problem statement provides a well-defined clinical scenario and a set of quantitative parameters for constructing a decision-analytic model. The data are internally consistent, scientifically grounded in medical and decision theory, and sufficient to derive a unique, principled solution. The problem is therefore valid.\n\n**Principle-Based Derivation of the Decision Algorithm**\n\nThe task is to construct an algorithm to choose between two actions: (1) Expectant Management (Wait  See) and (2) Immediate Intervention. The optimal choice is the one that minimizes the expected harm. We will use the provided facts to build a model based on expected value theory.\n\nLet $P$ be the posterior probability that the bleeding will cease spontaneously for a given patient.\nLet $h_c = 1$ be the normalized harm weight of a major procedural complication.\nLet $h_w = 0.05$ be the normalized harm weight of morbidity from continued bleeding.\nLet $P_{comp} = 0.01$ be the probability of a major complication from an intervention.\n\n1.  **Expected Harm of Immediate Intervention ($E[\\text{Harm}_{\\text{Intervene}}]$)**\n    If we intervene immediately, the only harm considered is that of a procedural complication.\n    $$ E[\\text{Harm}_{\\text{Intervene}}] = P_{comp} \\times h_c = 0.01 \\times 1 = 0.01 $$\n\n2.  **Expected Harm of Expectant Management ($E[\\text{Harm}_{\\text{Wait}}]$)**\n    If we choose expectant management, there are two outcomes:\n    - The bleeding ceases spontaneously, with probability $P$. In this case, there is no morbidity from continued bleeding and no procedure, so the harm is $0$.\n    - The bleeding does not cease spontaneously, with probability $(1-P)$. In this case, the patient suffers morbidity from continued bleeding (harm $h_w$). Following this, an intervention is required, which itself carries the expected harm of a complication ($P_{comp} \\times h_c$). Thus, the total harm for this branch is the sum of the harm from waiting and the harm from the subsequent necessary procedure.\n    The expected harm of waiting is therefore:\n    $$ E[\\text{Harm}_{\\text{Wait}}] = (P \\times 0) + ((1-P) \\times (h_w + P_{comp} \\times h_c)) $$\n    $$ E[\\text{Harm}_{\\text{Wait}}] = (1-P) \\times (0.05 + 0.01 \\times 1) = 0.06(1-P) $$\n\n3.  **Derivation of the Decision Threshold ($P_{threshold}$)**\n    The optimal strategy is expectant management if its expected harm is less than that of immediate intervention. The decision threshold is the probability $P$ at which the two strategies have equal expected harm.\n    $$ E[\\text{Harm}_{\\text{Wait}}] = E[\\text{Harm}_{\\text{Intervene}}] $$\n    $$ 0.06(1-P_{threshold}) = 0.01 $$\n    $$ 1 - P_{threshold} = \\frac{0.01}{0.06} = \\frac{1}{6} $$\n    $$ P_{threshold} = 1 - \\frac{1}{6} \\approx 0.8333 $$\n    The decision rule is: If the patient's posterior probability of spontaneous cessation $P_{\\text{posterior}}$ is greater than $P_{threshold} \\approx 0.8333$, choose expectant management. Otherwise, choose immediate intervention.\n\n4.  **Calculation of the Posterior Probability for the Patient ($P_{\\text{posterior}}$)**\n    We use Bayesian updating, starting with the prior probability and applying the relevant likelihood factors. It is computationally simpler to work with odds.\n    - Prior Probability of spontaneous cessation, $P_{prior} = 0.8$.\n    - Prior Odds = $\\frac{P_{prior}}{1 - P_{prior}} = \\frac{0.8}{1 - 0.8} = \\frac{0.8}{0.2} = 4$.\n\n    Now, we assess the patient's findings against the provided likelihood factors:\n    - **Hemodynamic stability**: The patient has a systolic blood pressure of $118$ mmHg, heart rate of $84$ bpm, no orthostatic changes, and a normal lactate of $1.2$ mmol/L. He is hemodynamically stable. The corresponding likelihood ratio ($LR_S$) is $1.5$.\n    - **Small hemoglobin drop**: The hemoglobin decreased from $13.4$ g/dL to $12.8$ g/dL, a change of $0.6$ g/dL. This is less than the $1$ g/dL cutoff. The corresponding likelihood ratio ($LR_H$) is $1.3$.\n    - **Observed ongoing hematochezia within the last hour**: The patient had two episodes over $6$ hours. The problem does not state that bleeding was observed in the last hour. Therefore, the likelihood ratio for ongoing hematochezia ($LR_O = 0.6$) is not applied.\n\n    The posterior odds are calculated by multiplying the prior odds by the applicable likelihood ratios:\n    $$ \\text{Posterior Odds} = \\text{Prior Odds} \\times LR_S \\times LR_H $$\n    $$ \\text{Posterior Odds} = 4 \\times 1.5 \\times 1.3 = 6 \\times 1.3 = 7.8 $$\n\n    Finally, we convert the posterior odds back to a probability:\n    $$ P_{\\text{posterior}} = \\frac{\\text{Posterior Odds}}{1 + \\text{Posterior Odds}} = \\frac{7.8}{1 + 7.8} = \\frac{7.8}{8.8} = \\frac{39}{44} \\approx 0.8864 $$\n\n5.  **Application of the Decision Rule to the Patient**\n    We compare the patient's posterior probability to the decision threshold:\n    $$ P_{\\text{posterior}} \\approx 0.8864 $$\n    $$ P_{threshold} \\approx 0.8333 $$\n    Since $P_{\\text{posterior}} > P_{\\text{threshold}}$, the principled algorithm indicates that **expectant management** is the optimal strategy for this patient.\n\n**Option-by-Option Analysis**\n\n**A. Screen first for hemodynamic instability...; if stable, estimate the probability of spontaneous cessation by Bayesian updating...; then compare the posterior probability to a decision threshold derived from expected-value balancing...; choose expectant management if the posterior probability exceeds the threshold...**\n\n- **Analysis**: This option provides a perfect abstract description of the formal decision-analytic process derived above. It correctly identifies all the key components: initial stability screen, Bayesian updating of probability, derivation of a threshold via expected-value balancing, the correct decision rule (comparing posterior probability to the threshold), and the inclusion of a dynamic element for reassessment. Applying this algorithm to the patient, as shown in our derivation, leads to the selection of expectant management.\n- **Verdict**: **Correct**.\n\n**B. Use a hemoglobin-only rule: if hemoglobin is below $10$ grams per deciliter, transfuse and observe; if hemoglobin is $10$ grams per deciliter or higher, perform immediate colonoscopy...**\n\n- **Analysis**: This option proposes a simplistic heuristic that ignores almost all of the information and principles provided in the problem statement. It disregards hemodynamic status, probability calculations, and the balancing of harms and benefits. For this patient, with a hemoglobin of $12.8$ g/dL, this rule would mandate immediate colonoscopy, which contradicts our finding that expectant management minimizes expected harm.\n- **Verdict**: **Incorrect**.\n\n**C. Use the number of bloody stools as the principal determinant: if more than $3$ bloody stools occur within $6$ hours, obtain immediate CTA; otherwise, discharge with outpatient colonoscopy...**\n\n- **Analysis**: This is another arbitrary, reductionist rule. It focuses on a single variable (stool frequency) and explicitly ignores hemodynamics, probability estimation, and procedural risk, which are the cornerstones of the required principled approach. For this patient (two stools), it would recommend discharge with outpatient colonoscopy. Discharging a patient with a confirmed hemoglobin drop from an active bleed is questionable, and the decision is not based on the rigorous framework required.\n- **Verdict**: **Incorrect**.\n\n**D. Apply a universal early-intervention pathway: for any LGIB with ongoing hematochezia on arrival, obtain immediate CTA followed by colonoscopy... do not incorporate probability-of-cessation estimates or expected-value balancing.**\n\n- **Analysis**: This option advocates for an aggressive, one-size-fits-all approach and explicitly rejects the core of the problem's task (\"do not incorporate probability-of-cessation estimates or expected-value balancing\"). Such a strategy would subject a patient with a high probability of spontaneous resolution to the unnecessary risks of an invasive procedure ($1\\%$ risk of a major complication). This violates the principle of minimizing expected harm.\n- **Verdict**: **Incorrect**.\n\nIn conclusion, Option A is the only choice that accurately describes the construction and application of a decision algorithm based on the established principles of decision analysis, using all the quantitative data provided in the problem.", "answer": "$$\\boxed{A}$$", "id": "4789178"}]}